Literature DB >> 18403592

Molecular and cytogenetic characterization of plexiform leiomyomata provide further evidence for genetic heterogeneity underlying uterine fibroids.

Jennelle C Hodge1, Bradley J Quade, Mark A Rubin, Elizabeth A Stewart, Paola Dal Cin, Cynthia C Morton.   

Abstract

The plexiform variant of uterine leiomyomata (UL) is named for its ribbons or nests of smooth muscle cells that have a rounded, epithelioid shape caused by their entrapment in abundant extracellular matrix. Plexiform UL are currently classified as epithelioid smooth muscle tumors alongside the less predictable, "true" epithelioid tumors (ie, leiomyoblastomas). Karyotypes of six plexiform UL cases were studied, and their abnormalities were found to differ from those of leiomyoblastomas. Analyses using real-time polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization demonstrated elevated mRNA and protein levels of the architectural factor HMGA2 and, in some cases, increased DNA copy number. Four of these plexiform UL were profiled with Affymetrix human U133 plus 2.0 expression arrays. Cluster analysis using genes previously shown to discriminate benign and malignant uterine smooth muscle tissues revealed that the plexiform tumors form an isolated group in the benign branch. This is in contrast to an earlier finding in which another variant, cellular UL characterized by loss of a portion of the short arm of chromosome 1, clustered with malignant leiomyosarcomas. These results provide additional evidence of genetic heterogeneity underlying UL of various histological types. We further suggest that plexiform UL should be classified among tumors with extensive hyalinization rather than with "true" epithelioid smooth muscle neoplasms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18403592      PMCID: PMC2329848          DOI: 10.2353/ajpath.2008.071102

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

1.  Intravenous leiomyomatosis is characterized by a der(14)t(12;14)(q15;q24).

Authors:  Paola Dal Cin; Bradley J Quade; David M Neskey; Michael S Kleinman; Stanislawa Weremowicz; Cynthia C Morton
Journal:  Genes Chromosomes Cancer       Date:  2003-02       Impact factor: 5.006

2.  The UCSC Genome Browser Database.

Authors:  D Karolchik; R Baertsch; M Diekhans; T S Furey; A Hinrichs; Y T Lu; K M Roskin; M Schwartz; C W Sugnet; D J Thomas; R J Weber; D Haussler; W J Kent
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

3.  HMGA2 expression in uterine leiomyomata and myometrium: quantitative analysis and tissue culture studies.

Authors:  Karen L Gross; David M Neskey; Nitasha Manchanda; Stanislawa Weremowicz; Michael S Kleinman; Romana A Nowak; Azra H Ligon; Piere Rogalla; Klaus Drechsler; Jörn Bullerdiek; Cynthia C Morton
Journal:  Genes Chromosomes Cancer       Date:  2003-09       Impact factor: 5.006

4.  Intravenous leiomyomatosis: molecular and cytogenetic analysis of a case.

Authors:  Bradley J Quade; P Dal Cin; D M Neskey; S Weremowicz; C C Morton
Journal:  Mod Pathol       Date:  2002-03       Impact factor: 7.842

5.  Annual costs associated with diagnosis of uterine leiomyomata.

Authors:  Katherine E Hartmann; Howard Birnbaum; Rym Ben-Hamadi; Eric Q Wu; Max H Farrell; James Spalding; Paul Stang
Journal:  Obstet Gynecol       Date:  2006-10       Impact factor: 7.661

6.  Misexpression of wild-type and truncated isoforms of the high-mobility group I proteins HMGI-C and HMGI(Y) in uterine leiomyomas.

Authors:  M Klotzbücher; A Wasserfall; U Fuhrmann
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

Review 7.  Molecular biology of HMGA proteins: hubs of nuclear function.

Authors:  R Reeves
Journal:  Gene       Date:  2001-10-17       Impact factor: 3.688

8.  Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling.

Authors:  Bradley J Quade; Tao-Yeuan Wang; Kris Sornberger; Paola Dal Cin; George L Mutter; Cynthia C Morton
Journal:  Genes Chromosomes Cancer       Date:  2004-06       Impact factor: 5.006

9.  Uterine leiomyomata with t(10;17) disrupt the histone acetyltransferase MORF.

Authors:  Steven D P Moore; Steven R Herrick; Tan A Ince; Michael S Kleinman; Paola Dal Cin; Cynthia C Morton; Bradley J Quade
Journal:  Cancer Res       Date:  2004-08-15       Impact factor: 12.701

10.  Integration of cytogenetic landmarks into the draft sequence of the human genome.

Authors:  V G Cheung; N Nowak; W Jang; I R Kirsch; S Zhao; X N Chen; T S Furey; U J Kim; W L Kuo; M Olivier; J Conroy; A Kasprzyk; H Massa; R Yonescu; S Sait; C Thoreen; A Snijders; E Lemyre; J A Bailey; A Bruzel; W D Burrill; S M Clegg; S Collins; P Dhami; C Friedman; C S Han; S Herrick; J Lee; A H Ligon; S Lowry; M Morley; S Narasimhan; K Osoegawa; Z Peng; I Plajzer-Frick; B J Quade; D Scott; K Sirotkin; A A Thorpe; J W Gray; J Hudson; D Pinkel; T Ried; L Rowen; G L Shen-Ong; R L Strausberg; E Birney; D F Callen; J F Cheng; D R Cox; N A Doggett; N P Carter; E E Eichler; D Haussler; J R Korenberg; C C Morton; D Albertson; G Schuler; P J de Jong; B J Trask
Journal:  Nature       Date:  2001-02-15       Impact factor: 49.962

View more
  8 in total

1.  Uterine cellular leiomyomata with chromosome 1p deletions represent a distinct entity.

Authors:  Jennelle C Hodge; Kathryn E Pearce; Amy C Clayton; Florin A Taran; Elizabeth A Stewart
Journal:  Am J Obstet Gynecol       Date:  2014-01-08       Impact factor: 8.661

2.  Clinico-pathological features of gynecological myopericytoma: a challenging diagnosis in an exceptional location.

Authors:  Fulvio Borella; Fabiola Lucchino; Luca Bertero; Marisa Ribotta; Isabella Castellano; Andrea Carosso; Stefano Cosma; Dionyssios Katsaros; Chiara Benedetto
Journal:  Virchows Arch       Date:  2019-08-13       Impact factor: 4.064

3.  Molecular profiling of endometrial malignancies.

Authors:  Norasate Samarnthai; Kevin Hall; I-Tien Yeh
Journal:  Obstet Gynecol Int       Date:  2010-03-28

4.  Factors associated with uterine fibroid in Ghanaian women undergoing pelvic scans with suspected uterine fibroid.

Authors:  Benjamin Dabo Sarkodie; Benard Ohene Botwe; David Nana Adjei; Eric Ofori
Journal:  Fertil Res Pract       Date:  2016-05-01

5.  Intravenous leiomyomatosis: an unusual intermediate between benign and malignant uterine smooth muscle tumors.

Authors:  Zehra Ordulu; Marisa R Nucci; Paola Dal Cin; Monica L Hollowell; Christopher N Otis; Jason L Hornick; Peter J Park; Tae-Min Kim; Bradley J Quade; Cynthia C Morton
Journal:  Mod Pathol       Date:  2016-02-19       Impact factor: 7.842

6.  Evidence of biomechanical and collagen heterogeneity in uterine fibroids.

Authors:  Friederike L Jayes; Betty Liu; Liping Feng; Nydea Aviles-Espinoza; Sergey Leikin; Phyllis C Leppert
Journal:  PLoS One       Date:  2019-04-29       Impact factor: 3.240

Review 7.  Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment.

Authors:  Qiwei Yang; Michal Ciebiera; Maria Victoria Bariani; Mohamed Ali; Hoda Elkafas; Thomas G Boyer; Ayman Al-Hendy
Journal:  Endocr Rev       Date:  2022-07-13       Impact factor: 25.261

8.  Uterine fibroid characteristics and sonographic pattern among Ghanaian females undergoing pelvic ultrasound scan: a study at 3-major centres.

Authors:  Benjamin Dabo Sarkodie; Benard Ohene Botwe; Eric K Ofori
Journal:  BMC Womens Health       Date:  2016-02-16       Impact factor: 2.809

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.